Loading...
Core Scientific Inc (CORZ) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. While there are positive catalysts such as bullish analyst ratings and a pivot to high-performance computing, the company's weak financial performance, declining revenue, and negative sentiment from recent news suggest caution. The technical indicators are mixed, and no strong proprietary trading signals are present to justify immediate action.
The technical indicators show mixed signals. The MACD is positive and expanding, indicating bullish momentum. The RSI is neutral at 56.028, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock has faced recent price declines, with a pre-market change of -0.17%, regular market change of -0.55%, and post-market change of -1.45%. Key support and resistance levels are Pivot: 17.484, R1: 18.309, and S1: 16.659.

Analysts have raised price targets and upgraded the stock, citing strong growth prospects in high-performance computing (HPC).
Hedge funds are increasing their positions, with a 104.24% rise in buying over the last quarter.
The company is pivoting from Bitcoin mining to HPC leasing, which aligns with industry trends.
Weak financial performance in Q3 2025, with revenue down 14.95% YoY, net income down 57.05% YoY, and EPS down 60.68% YoY.
Negative news sentiment, including profit declines in Bitcoin mining and significant share reductions by Paloma Partners Management Co.
No recent Congress trading data or strong proprietary trading signals to support immediate action.
The company's Q3 2025 financials show significant declines: revenue dropped to $81.1M (-14.95% YoY), net income dropped to -$147.5M (-57.05% YoY), EPS dropped to -0.46 (-60.68% YoY), and gross margin dropped to 4.81 (-3106.25% YoY). These figures indicate poor financial health and declining profitability.
Analysts are bullish on the stock. Keefe Bruyette raised the price target to $25 from $19, BTIG upgraded the stock to Buy with a $23 target, and Citizens upgraded it to Outperform with a $30 target. Analysts highlight the company's pivot to HPC leasing and its undervaluation in the expanding HPC data center industry.